Literature DB >> 10736493

The tension-free vaginal tape procedure: correction of stress incontinence with minimal alteration in proximal urethral mobility.

J J Klutke1, B I Carlin, C G Klutke.   

Abstract

OBJECTIVES: To prospectively assess the degree of urethral hypermobility in the preoperative and postoperative periods after the tension-free vaginal tape (TVT) procedure and correlate our findings with surgical outcome.
METHODS: Twenty patients with stress incontinence underwent the TVT procedure. A Q-tip test was performed before the procedure and at the 3-week postoperative follow-up visit. Cure was defined as the absence of the subjective complaint of urine leakage and the absence of stress incontinence on stress testing at cystometric capacity.
RESULTS: Seventeen patients (85%) were cured by the TVT procedure, 2 patients (10%) were improved, and 1 patient (5%) was unchanged. The mean preoperative and postoperative Q-tip values were 42.75 degrees and 31.75 degrees, respectively. Twelve patients had a Q-tip test result of 30 degrees or greater after surgery and 11 (92%) of these 12 patients were cured by the procedure.
CONCLUSIONS: On the basis of these results, we propose that the cure of stress incontinence does not require the correction of proximal urethral hypermobility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736493     DOI: 10.1016/s0090-4295(99)00551-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

1.  The prevalence of voiding difficulty after TVT, its impact on quality of life, and related risk factors.

Authors:  Harry A M Vervest; Tanya M Bisseling; A Peter M Heintz; Steven E Schraffordt Koops
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-22

Review 2.  Nonautologous sling materials.

Authors:  G M Ghoniem; D S Kapoor
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

Review 3.  A review of the tension-free vaginal tape procedure: outcomes, complications, and theories.

Authors:  M M Brophy; J J Klutke; C G Klutke
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

4.  The effects of the tension-free vaginal tape on proximal urethral position: a prospective, longitudinal evaluation.

Authors:  Emily S Lukacz; Karl M Luber; Charles W Nager
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-04-26

5.  The clinical and urodynamic effects of the tension free bladder neck sling procedure.

Authors:  Cheng-Yu Long; Shih-Cheng Hsu; Yu Chang; Yu-Chieh Chen; Juin-Huang Su; Eing-Mei Tsai
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-06-04

6.  The efficacy of the tension-free vaginal tape in the treatment of five subtypes of stress urinary incontinence.

Authors:  Jeffrey L Segal; Brett J Vassallo; Steven D Kleeman; Melanie Hungler; Mickey M Karram
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-18

Review 7.  Artificial graft slings at the midurethra: physiology of continence.

Authors:  Jennifer Tash; David R Staskin
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 3.092

8.  Comparing the risk of urethrolysis for the treatment of voiding dysfunction between two retropubic mesh slings: a case-control study.

Authors:  Amie Kawasaki; Autumn L Edenfield; Anthony G Visco; Jennifer M Wu; Daniel Westreich; Nazema Y Siddiqui
Journal:  Int Urogynecol J       Date:  2012-08-22       Impact factor: 2.894

9.  Urethral hypermobility after anti-incontinence surgery - a prognostic indicator?

Authors:  Volker Viereck; Hans-Ulrich Pauer; Oda Hesse; Werner Bader; Ralf Tunn; Rainer Lange; Reinhard Hilgers; Günter Emons
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-15

10.  Measurement of the Q-tip angle before and after tension-free vaginal tape-obturator (TVT-O): preoperative urethral mobility may predict surgical outcome.

Authors:  Sun-Ouck Kim; Ho Seok Jung; Won Seok Jang; In Sang Hwang; Ho Song Yu; Dongdeuk Kwon
Journal:  Int Urogynecol J       Date:  2012-11-14       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.